146 related articles for article (PubMed ID: 3256109)
41. The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
Cortese L; Pelagalli A; Piantedosi D; Mastellone V; Di Loria A; Lombardi P; Ciaramella P; Avallone L
Vet J; 2008 Sep; 177(3):405-10. PubMed ID: 17629526
[TBL] [Abstract][Full Text] [Related]
42. Glomerulonephritis in dogs with canine leishmaniasis.
Benderitter T; Casanova P; Nashkidachvili L; Quilici M
Ann Trop Med Parasitol; 1988 Aug; 82(4):335-41. PubMed ID: 3252757
[TBL] [Abstract][Full Text] [Related]
43. Dynamics of Leishmania-specific immunoglobulin isotypes in dogs with clinical leishmaniasis before and after treatment.
Rodríguez A; Solano-Gallego L; Ojeda A; Quintana J; Riera C; Gállego M; Portús M; Alberola J
J Vet Intern Med; 2006; 20(3):495-8. PubMed ID: 16734080
[TBL] [Abstract][Full Text] [Related]
44. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
Font A; Gines C; Closa JM; Mascort J
J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
[TBL] [Abstract][Full Text] [Related]
45. Fulminant hepatitis in an Italian infant with visceral leishmaniasis.
di Martino L; Vajro P; Nocerino A; Scotti S; Napolitano G; Vegnente A
Trans R Soc Trop Med Hyg; 1992; 86(1):34. PubMed ID: 1566298
[No Abstract] [Full Text] [Related]
46. Evaluation of 65% permethrin spot-on for prevention of canine visceral leishmaniasis: effect on disease prevalence and the vectors (Diptera: Psychodidae) in a hyperendemic area.
Giffoni JH; de Almeida CE; dos Santos SO; Ortega VS; de Barros AT
Vet Ther; 2002; 3(4):485-92. PubMed ID: 12584686
[TBL] [Abstract][Full Text] [Related]
47. Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment.
Cantos-Barreda A; Escribano D; Cerón JJ; Tecles F; Bernal LJ; Martínez-Subiela S
Vet Parasitol; 2018 Apr; 254():135-141. PubMed ID: 29656998
[TBL] [Abstract][Full Text] [Related]
48. Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.
Cardoso JMO; Brito RCF; Mathias FAS; Reis LES; Vieira JFP; Ostolin TLVDP; Andrade HM; Ramos GS; Frézard F; Aguiar-Soares RDO; Roatt BM; Reis AB
Mol Immunol; 2022 Jan; 141():70-78. PubMed ID: 34814056
[TBL] [Abstract][Full Text] [Related]
49. Treatment of canine Old World visceral leishmaniasis: a systematic review.
Noli C; Auxilia ST
Vet Dermatol; 2005 Aug; 16(4):213-32. PubMed ID: 16101793
[TBL] [Abstract][Full Text] [Related]
50. Comparison of efficacy and safety of preventive measures used against canine leishmaniasis in southern European countries: Longitudinal retrospective study in 1647 client-owned dogs (2012-2016).
Fernandez M; Tabar MD; Arcas A; Mateu C; Homedes J; Roura X
Vet Parasitol; 2018 Nov; 263():10-17. PubMed ID: 30389018
[TBL] [Abstract][Full Text] [Related]
51. Deltamethrin-impregnated collars for the control of canine leishmaniasis: evaluation of the protective effect and influence on the clinical outcome of Leishmania infection in kennelled stray dogs.
Foglia Manzillo V; Oliva G; Pagano A; Manna L; Maroli M; Gradoni L
Vet Parasitol; 2006 Nov; 142(1-2):142-5. PubMed ID: 16884851
[TBL] [Abstract][Full Text] [Related]
52. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
53. Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs.
Valladares JE; Alberola J; Esteban M; Arboix M
Vet Rec; 1996 Feb; 138(8):181-3. PubMed ID: 8677619
[TBL] [Abstract][Full Text] [Related]
54. Clinical follow-up examination after treatment of canine leishmaniasis.
Moritz A; Steuber S; Greiner M
Tokai J Exp Clin Med; 1998 Dec; 23(6):279-83. PubMed ID: 10622623
[TBL] [Abstract][Full Text] [Related]
55. Seizures as a Consequence of Hyperviscosity Syndrome in Two Dogs Naturally Infected with Leishmania infantum.
Proverbio D; Spada E; Perego R; de Giorgi GB
J Am Anim Hosp Assoc; 2016; 52(2):119-23. PubMed ID: 26808431
[TBL] [Abstract][Full Text] [Related]
56. Detection of Leishmania amastigotes in peripheral blood from four dogs--Short communication.
Giudice E; Passantino A
Acta Vet Hung; 2011 Jun; 59(2):205-13. PubMed ID: 21665574
[TBL] [Abstract][Full Text] [Related]
57. [Evaluation of control measures for visceral leishmaniasis (kala azar) in an endemic area in Bahia, Brazil (1995-2000)].
de Oliveira SS; de Araújo TM
Cad Saude Publica; 2003; 19(6):1681-90. PubMed ID: 14999334
[TBL] [Abstract][Full Text] [Related]
58. Prevalence of visceral leishmaniasis in A population of free-roaming dogs as determined by multiple sampling efforts: A longitudinal study analyzing the effectiveness of euthanasia.
Melo SN; Teixeira-Neto RG; Werneck GL; Struchiner CJ; Ribeiro RAN; Sousa LR; de Melo MOG; Carvalho Júnior CG; Penaforte KM; Manhani MN; Aquino VV; Silva ES; Belo VS
Prev Vet Med; 2018 Dec; 161():19-24. PubMed ID: 30466654
[TBL] [Abstract][Full Text] [Related]
59. Chemotherapy of canine leishmaniosis.
Baneth G; Shaw SE
Vet Parasitol; 2002 Jul; 106(4):315-24. PubMed ID: 12079737
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the cardiac toxicity of N-methyl-glucamine antimoniate in dogs with naturally occurring leishmaniasis.
Luciani A; Sconza S; Civitella C; Guglielmini C
Vet J; 2013 Apr; 196(1):119-21. PubMed ID: 23021954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
